Contemporary management of patients with HFrEF

  Topic Faculty
12:45–12:48 Welcome and introduction Faiez Zannad (France) and
John McMurray (UK)
12:48–12:58 One year after updating the heart failure guidelines – has the management of patients with HFrEF changed? John McMurray (UK)
12:58–13:28 Managing contemporary HFrEF therapies – clinical case discussion Peter van der Meer (The Netherlands)
13:28–13:58 Optimising contemporary HFrEF therapies in patients with comorbidities – clinical case discussion Frank Ruschitzka (Switzerland)
13:58–14:00 Summary and key learning points Faiez Zannad (France)

The learning objectives for this open forum expert discussion focused on:

  • Understand how the latest guidelines and clinical evidence impact clinical practice in the treatment of heart failure with reduced ejection fraction
  • Understand the use of evidence-based treatments in different patient types with heart failure with reduced ejection fraction
  • Appreciate the importance of patient follow-up to ensure optimal treatment management to achieve improved care
  • Cardiologists
  • Heart Failure Specialists

 

Novartis sponsored satellite symposium at Heart Failure 2017 & 4th World Congress on Acute Failure
©2017 Novartis Pharma AG, CH-4002 Basel – March 2017 – GLCM/HTF/0408